When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
VYNE Therapeutics ([[VYNE]] +4.3%) has announced a coverage update for its ZILXI topical foam, 1.5%, FDA approved minocycline product for use in rosacea for the treatment of inflammatory lesions in adults.Express Scripts has elected to cover ZILXI effective October 2, on Express Scripts' National Preferred, Flex, and Basic commercial formularies.The annual list price of ZILXI is $485 per 30-gram canister.